ESPOIR Co.,Ltd. (XNGO:3260)
Japan
· Delayed Price · Currency is JPY 3,295.00
-15.00 (-0.45%)
At close: May 1, 2025
ESPOIR Revenue
In the fiscal year ending February 28, 2025, ESPOIR had annual revenue of 306.00M JPY, down -56.78%. ESPOIR had revenue of 132.00M in the quarter ending February 28, 2025, with 355.17% growth.
Revenue
306.00M
Revenue Growth
-56.78%
P/S Ratio
20.50
Revenue / Employee
102.00M
Employees
3
Market Cap
6.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 306.00M | -402.00M | -56.78% |
| Feb 29, 2024 | 708.00M | -687.00M | -49.25% |
| Feb 28, 2023 | 1.40B | -88.00M | -5.93% |
| Feb 28, 2022 | 1.48B | 48.00M | 3.34% |
| Feb 28, 2021 | 1.44B | 38.00M | 2.72% |
| Feb 29, 2020 | Pro | Pro | Pro |
| Feb 28, 2019 | Pro | Pro | Pro |
| Feb 28, 2010 | Pro | Pro | Pro |
| Feb 28, 2009 | Pro | Pro | Pro |
| Feb 29, 2008 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Toyota Motor | 46.75T |
| Sony Group | 13.81T |
| Mitsubishi UFJ Financial Group | 6,199.27B |
| Hitachi | 9,783.37B |
| Keyence | 1,059.15B |
| Fast Retailing | 3,295.04B |
| Chugai Pharmaceutical | 1,222.12B |
| Nintendo | 1,233.29B |